A

AC Immune SA
D

ACIU

2.46000
USD
0.02
(0.82%)
مغلق
حجم التداول
3,256
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
247,476,000
أصول ذات صلة
A
ABCL
0.09000
(1.79%)
5.10500 USD
A
ALLO
-0.01000
(-0.66%)
1.49500 USD
G
GH
-1.035
(-2.28%)
44.450 USD
I
IBRX
-0.14000
(-4.67%)
2.86000 USD
K
KURA
-0.23500
(-3.64%)
6.22500 USD
MRNA
MRNA
0.125
(0.37%)
34.145 USD
R
RPTX
0.01000
(0.64%)
1.57000 USD
V
VIR
-0.11000
(-1.91%)
5.65000 USD
R
RR
-0.04500
(-2.19%)
2.01000 USD
المزيد
الأخبار المقالات

العنوان: AC Immune SA

القطاع: Healthcare
الصناعة: Biotechnology
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.